High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5341-5351

  Wetherill, Laura F ^a   Holmes, Kristopher K ^a   Verow, Mark ^a   Müller, Marietta ^a   Howell, Gareth ^a   Harris, Mark ^a   Fishwick, Colin ^a   Stonehouse, Nicola ^a   Foster, Richard ^a   Blair, G Eric ^a   Griffin, Stephen ^b   Macdonald, Andrew ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; LIPOSOME; OLIGOMER; ONCOPROTEIN; PROTEIN E5; PROTEIN INHIBITOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIROPORIN; VIRUS PROTEIN;

ARTICLE; CHANNEL FORMING ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; MOLECULAR MODEL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STOICHIOMETRY; VIRUS ENVELOPE;

ADAMANTANE; ANIMALS; CELL LINE; CRICETINAE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCEINS; GENE ORDER; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; ONCOGENE PROTEINS, VIRAL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINANT FUSION PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84861326301     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06243-11     Document Type: Article

References (41)

1. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS. 2005. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int. J. Cancer 113:276-283.
2. Chang JL, et al. 2001. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J. Biomed. Sci. 8:206-213.
3. Clarke D, et al. 2006. Evidence for the formation of a heptameric ion channel complex by the hepatitisCvirus p7 protein in vitro. J. Biol. Chem. 281:37057-37068.
4. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
5. Disbrow GL, Hanover JA, Schlegel R. 2005. Endoplasmic reticulumlocalized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J. Virol. 79:5839-5846.
6. Duff KC, Ashley RH. 1992. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology 190:485-489.
7. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. 1997. Empirical scoring functions. I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput. Aided Mol. Des. 11:425-445.
8. Fehrmann F, Klumpp DJ, Laimins LA. 2003. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77:2819-2831.
9. Feige JN, Sage D, Wahli W, Desvergne B, Gelman L. 2005. PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc. Res. Tech. 68:51-58.
10. Foster TL, et al. 2011. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus (HCV) p7 ion channel. Hepatology 54:79-90.
11. Friesner RA, et al. 2004. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47:1739-1749.
12. Gamlen T, et al. 2010. Expression of the NS3 protease of cytopathogenic bovine viral diarrhea virus results in the induction of apoptosis but does not block activation of the beta interferon promoter. J. Gen. Virol. 91:133-144.
13. Gao P, Zheng J. 2010. High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer. Virol. J. 7:238.
14. Genther SM, et al. 2003. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77:2832-2842.
15. Genther Williams SM, et al. 2005. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65:6534-6542.
16. Gieswein CE, Sharom FJ, Wildeman AG. 2003. Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology 313:415-426.
17. Gonzalez ME, Carrasco L. 2003. Viroporins. FEBS Lett. 552:28-34.
18. Griffin S, et al. 2008. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology 48:1779-1790.
19. Griffin SD. 2009. Plugging the holes in hepatitis C virus antiviral therapy. Proc. Natl. Acad. Sci. U. S. A. 106:12567-12568.
20. Griffin SD, et al. 2003. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine. FEBS Lett. 535: 34-38.
21. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific anti-influenza action of amantadine.EMBOJ. 4:3021-3024.
22. Intharathep P, et al. 2008. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J. Mol. Graph. Model. 27: 342-348.
23. Kell B, et al. 1994. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J. Gen. Virol. 75(Pt 9):2451-2456.
24. Krawczyk E, Suprynowicz FA, Sudarshan SR, Schlegel R. 2010. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein. J. Virol. 84:1696-1703.
25. Ladokhin AS, Selsted ME, White SH. 1997. Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys. J. 72:1762-1766.
26. Luik P, et al. 2009. The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc. Natl. Acad. Sci. U. S. A. 106: 12712-12716.
27. Macdonald A, et al. 2003. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J. Biol. Chem. 278:17775-17784.
28. Mankouri J, et al. 2010. Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog. 6:e1000778.
29. Maufort JP, Shai A, Pitot HC, Lambert PF. 2010. A role for HPV16 E5 in cervical carcinogenesis. Cancer Res. 70:2924-2931.
30. Maufort JP, Williams SM, Pitot HC, Lambert PF. 2007. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res. 67:6106-6112.
31. McFadden N, et al. 2011. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 7:e1002413.
32. Oh JM, et al. 2010. Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitinproteasome- mediated degradation of Bax in human cervical cancer cells. Carcinogenesis 31:402-410.
33. Park SC, et al. 2006. Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. Biochem. Biophys. Res. Commun. 343:222-228.
34. Pim D, Collins M, Banks L. 1992. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7:27-32.
35. Sanz MA, Madan V, Carrasco L, Nieva JL. 2003. Interfacial domains in Sindbis virus 6K protein. Detection and functional characterization. J. Biol. Chem. 278:2051-2057.
36. StGelais C, et al. 2007. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system. Antiviral Res. 76:48-58.
37. Stoler MH, et al. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:117-128.
38. Straight SW, Hinkle PM, Jewers RJ, McCance DJ. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
39. Studier FW. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.
40. Suprynowicz FA, et al. 2010. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J. Virol. 84:10619-10629.
41. Yang DH, Wildeman AG, Sharom FJ. 2003. Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16. Protein Expr. Purif. 30:1-10.